We would like to inform you that Viatris, the marketing authorisation holder for Creon^® has decided to increase the capsule length of Creon^® 25000 from 21.7mm to 24.2mm. The diameter of the capsule will not change.

The new size of Creon^® 25000 capsule does not affect the efficacy of the product and should not have an impact on the patient’s ability to swallow the capsules whole.